RU2002120897A - Производные аминометилфенилциклогексанона - Google Patents
Производные аминометилфенилциклогексанонаInfo
- Publication number
- RU2002120897A RU2002120897A RU2002120897/04A RU2002120897A RU2002120897A RU 2002120897 A RU2002120897 A RU 2002120897A RU 2002120897/04 A RU2002120897/04 A RU 2002120897/04A RU 2002120897 A RU2002120897 A RU 2002120897A RU 2002120897 A RU2002120897 A RU 2002120897A
- Authority
- RU
- Russia
- Prior art keywords
- unsubstituted
- mono
- alkyl
- unbranched
- branched
- Prior art date
Links
- NWSCVDPHHGDSBE-UHFFFAOYSA-N 2-(aminomethyl)-2-phenylcyclohexan-1-one Chemical class C=1C=CC=CC=1C1(CN)CCCCC1=O NWSCVDPHHGDSBE-UHFFFAOYSA-N 0.000 title claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 73
- 125000004432 carbon atom Chemical group C* 0.000 claims 56
- 229920006395 saturated elastomer Polymers 0.000 claims 47
- 229910052799 carbon Inorganic materials 0.000 claims 46
- 125000000217 alkyl group Chemical group 0.000 claims 44
- 125000000753 cycloalkyl group Chemical group 0.000 claims 33
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 32
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 32
- 125000000623 heterocyclic group Chemical group 0.000 claims 28
- 229910052760 oxygen Inorganic materials 0.000 claims 28
- 229910052717 sulfur Inorganic materials 0.000 claims 28
- 125000003118 aryl group Chemical group 0.000 claims 24
- 229910052801 chlorine Inorganic materials 0.000 claims 24
- 229910052731 fluorine Inorganic materials 0.000 claims 24
- 125000001072 heteroaryl group Chemical group 0.000 claims 18
- 125000002877 alkyl aryl group Chemical group 0.000 claims 16
- 229910052794 bromium Inorganic materials 0.000 claims 15
- 229910052740 iodine Inorganic materials 0.000 claims 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 10
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 9
- 239000002253 acid Substances 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 125000001624 naphthyl group Chemical group 0.000 claims 7
- 239000012458 free base Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000000047 product Substances 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 5
- UFXPDNGKMSEVHV-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(3-hydroxyphenyl)cyclohexan-1-one Chemical compound CN(C)CC1CCC(=O)CC1C1=CC=CC(O)=C1 UFXPDNGKMSEVHV-UHFFFAOYSA-N 0.000 claims 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 4
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 239000013543 active substance Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- BFQUXINHKGBHLT-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-4-[(dimethylamino)methyl]cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=C(F)C(F)=C1 BFQUXINHKGBHLT-UHFFFAOYSA-N 0.000 claims 2
- IANBCHYJKGEOEV-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-4-[(dimethylamino)methyl]cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC(Cl)=CC(Cl)=C1 IANBCHYJKGEOEV-UHFFFAOYSA-N 0.000 claims 2
- BAPSMKYJGSSKKI-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-4-[(dimethylamino)methyl]cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC(F)=CC(F)=C1 BAPSMKYJGSSKKI-UHFFFAOYSA-N 0.000 claims 2
- KQKZQCQYVBWYHB-UHFFFAOYSA-N 3-[3-(difluoromethyl)phenyl]-4-[(dimethylamino)methyl]cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=CC(C(F)F)=C1 KQKZQCQYVBWYHB-UHFFFAOYSA-N 0.000 claims 2
- NCZWDXKBNIMFQP-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(3-fluorophenyl)cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=CC(F)=C1 NCZWDXKBNIMFQP-UHFFFAOYSA-N 0.000 claims 2
- FQUDADXUSNUPMC-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(3-hydroxyphenyl)cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=CC(O)=C1 FQUDADXUSNUPMC-UHFFFAOYSA-N 0.000 claims 2
- QRQZXONDVGVNQH-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(3-methoxyphenyl)cyclohex-2-en-1-one Chemical compound COC1=CC=CC(C=2C(CCC(=O)C=2)CN(C)C)=C1 QRQZXONDVGVNQH-UHFFFAOYSA-N 0.000 claims 2
- RUBAZYTVFGSKSK-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(4-fluorophenyl)cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=C(F)C=C1 RUBAZYTVFGSKSK-UHFFFAOYSA-N 0.000 claims 2
- UJAURWYSPLJUMU-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(4-methoxyphenyl)cyclohex-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)CCC1CN(C)C UJAURWYSPLJUMU-UHFFFAOYSA-N 0.000 claims 2
- KMCQGZMJLRZRSV-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-(6-methoxynaphthalen-2-yl)cyclohex-2-en-1-one Chemical compound C1=CC2=CC(OC)=CC=C2C=C1C1=CC(=O)CCC1CN(C)C KMCQGZMJLRZRSV-UHFFFAOYSA-N 0.000 claims 2
- HNWYHTFBGUFONL-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-[4-(trifluoromethyl)phenyl]cyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=C(C(F)(F)F)C=C1 HNWYHTFBGUFONL-UHFFFAOYSA-N 0.000 claims 2
- PKXKHMUMACVYHM-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-hydroxy-3-(3-methoxyphenyl)cyclohexan-1-one Chemical compound COC1=CC=CC(C2(O)C(CCC(=O)C2)CN(C)C)=C1 PKXKHMUMACVYHM-UHFFFAOYSA-N 0.000 claims 2
- QSYOGYPHPHSUMF-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-naphthalen-2-ylcyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=C(C=CC=C2)C2=C1 QSYOGYPHPHSUMF-UHFFFAOYSA-N 0.000 claims 2
- SKCVIWLQHBSPFI-UHFFFAOYSA-N 4-[(dimethylamino)methyl]-3-phenylcyclohex-2-en-1-one Chemical compound CN(C)CC1CCC(=O)C=C1C1=CC=CC=C1 SKCVIWLQHBSPFI-UHFFFAOYSA-N 0.000 claims 2
- SROFOCUMLZWZIM-WFASDCNBSA-N CN(C)C[C@@H]1CCC(=O)C[C@H]1C1=CC=CC(F)=C1 Chemical compound CN(C)C[C@@H]1CCC(=O)C[C@H]1C1=CC=CC(F)=C1 SROFOCUMLZWZIM-WFASDCNBSA-N 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 229940126601 medicinal product Drugs 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- HJPSHWFGNDBKHV-BBRMVZONSA-N (3R,4R)-4-[(dimethylamino)methyl]-3-(3-methoxyphenyl)cyclohexan-1-one Chemical compound COC1=CC=CC([C@H]2[C@@H](CCC(=O)C2)CN(C)C)=C1 HJPSHWFGNDBKHV-BBRMVZONSA-N 0.000 claims 1
- HJPSHWFGNDBKHV-CJNGLKHVSA-N (3R,4S)-4-[(dimethylamino)methyl]-3-(3-methoxyphenyl)cyclohexan-1-one Chemical compound COC1=CC=CC([C@H]2[C@H](CCC(=O)C2)CN(C)C)=C1 HJPSHWFGNDBKHV-CJNGLKHVSA-N 0.000 claims 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- NHFVEBWIBVLQKP-UHFFFAOYSA-N 3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-10-one Chemical compound O1CC(C)(C)COC11CC(=O)CCC1 NHFVEBWIBVLQKP-UHFFFAOYSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- RREANTFLPGEWEN-MBLPBCRHSA-N 7-[4-[[(3z)-3-[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]imino-5-fluoro-2-oxoindol-1-yl]methyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(\N=C/3C4=CC(F)=CC=C4N(CN4CCN(CC4)C=4C(=CC=5C(=O)C(C(O)=O)=CN(C=5C=4)C4CC4)F)C\3=O)=NC=2)N)=C1 RREANTFLPGEWEN-MBLPBCRHSA-N 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- GBJBAKOEQBLBPL-ZFWWWQNUSA-N CN(C)C[C@@H]1CCC(=O)C[C@H]1C1=CC=CC=C1 Chemical compound CN(C)C[C@@H]1CCC(=O)C[C@H]1C1=CC=CC=C1 GBJBAKOEQBLBPL-ZFWWWQNUSA-N 0.000 claims 1
- SROFOCUMLZWZIM-DOMZBBRYSA-N CN(C)C[C@H]1CCC(=O)C[C@H]1C1=CC=CC(F)=C1 Chemical compound CN(C)C[C@H]1CCC(=O)C[C@H]1C1=CC=CC(F)=C1 SROFOCUMLZWZIM-DOMZBBRYSA-N 0.000 claims 1
- GBJBAKOEQBLBPL-HIFRSBDPSA-N CN(C)C[C@H]1CCC(=O)C[C@H]1C1=CC=CC=C1 Chemical compound CN(C)C[C@H]1CCC(=O)C[C@H]1C1=CC=CC=C1 GBJBAKOEQBLBPL-HIFRSBDPSA-N 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010011224 Cough Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002902 organometallic compounds Chemical class 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- -1 sodium amine Chemical class 0.000 claims 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C225/18—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10000311A DE10000311A1 (de) | 2000-01-05 | 2000-01-05 | Aminomethyl-Phonyl-Cyclohexanonderivate |
| DE10000311.7 | 2000-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002120897A true RU2002120897A (ru) | 2004-01-10 |
Family
ID=7626852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002120897/04A RU2002120897A (ru) | 2000-01-05 | 2000-12-27 | Производные аминометилфенилциклогексанона |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6890959B2 (enExample) |
| EP (1) | EP1246791B1 (enExample) |
| JP (1) | JP2003519209A (enExample) |
| KR (1) | KR100748378B1 (enExample) |
| CN (1) | CN100467441C (enExample) |
| AR (1) | AR030683A1 (enExample) |
| AT (1) | ATE280752T1 (enExample) |
| AU (1) | AU782862B2 (enExample) |
| BR (1) | BR0016941A (enExample) |
| CA (1) | CA2396310A1 (enExample) |
| CO (1) | CO5261627A1 (enExample) |
| CZ (1) | CZ20022338A3 (enExample) |
| DE (2) | DE10000311A1 (enExample) |
| DK (1) | DK1246791T3 (enExample) |
| ES (1) | ES2231304T3 (enExample) |
| HU (1) | HUP0203859A3 (enExample) |
| IL (2) | IL150558A0 (enExample) |
| MX (1) | MXPA02006697A (enExample) |
| NO (1) | NO20022983L (enExample) |
| NZ (1) | NZ520468A (enExample) |
| PE (1) | PE20011043A1 (enExample) |
| PL (1) | PL356642A1 (enExample) |
| PT (1) | PT1246791E (enExample) |
| RU (1) | RU2002120897A (enExample) |
| SI (1) | SI1246791T1 (enExample) |
| SK (1) | SK286799B6 (enExample) |
| WO (1) | WO2001049651A2 (enExample) |
| ZA (1) | ZA200206150B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7457762B2 (en) * | 2001-09-04 | 2008-11-25 | Accenture Global Services Gmbh | Optimization of management of maintenance, repair and overhaul of equipment in a specified time window |
| DE10326097A1 (de) * | 2003-06-06 | 2005-01-05 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen |
| DE10328316A1 (de) | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| US7260408B2 (en) * | 2004-02-20 | 2007-08-21 | Airespace, Inc. | Wireless node location mechanism using antenna pattern diversity to enhance accuracy of location estimates |
| US20050236892A1 (en) * | 2004-04-27 | 2005-10-27 | Akihito Kusano | Hydraulic braking pressure generating apparatus for vehicles |
| DE102005052588A1 (de) * | 2005-11-02 | 2007-05-10 | Grünenthal GmbH | Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse |
| TWI496762B (zh) | 2006-07-24 | 2015-08-21 | 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法 | |
| JP5009736B2 (ja) * | 2007-10-15 | 2012-08-22 | 日本曹達株式会社 | 環状アミノエーテルを用いたマンニッヒ反応 |
| WO2009106336A1 (de) * | 2008-02-29 | 2009-09-03 | Grünenthal GmbH | Verfahren zur herstellung von (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexan-1,3-diol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1518663A1 (de) * | 1965-08-02 | 1969-12-18 | Gruenenthal Chemie | Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung |
| US3652589A (en) * | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| US3974157A (en) * | 1974-03-04 | 1976-08-10 | Pennwalt Corporation | 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters |
| JPS51143650A (en) * | 1975-06-06 | 1976-12-10 | Takeda Chem Ind Ltd | A process for preparing cyclohexanol derivatives |
| DE69029668T2 (de) | 1989-03-08 | 1997-08-07 | Merck Sharp & Dohme | Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten |
| IL112569A (en) * | 1994-02-10 | 1999-12-22 | Wyeth John & Brother Ltd | Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation |
| DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE19547766A1 (de) * | 1995-12-20 | 1997-06-26 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe |
| DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| MY125037A (en) | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| DE19830105C1 (de) * | 1998-07-06 | 2000-02-17 | Gruenenthal Gmbh | Acridinderivate |
-
2000
- 2000-01-05 DE DE10000311A patent/DE10000311A1/de not_active Withdrawn
- 2000-12-27 BR BR0016941-2A patent/BR0016941A/pt not_active Application Discontinuation
- 2000-12-27 CZ CZ20022338A patent/CZ20022338A3/cs unknown
- 2000-12-27 PL PL00356642A patent/PL356642A1/xx unknown
- 2000-12-27 KR KR1020027008706A patent/KR100748378B1/ko not_active Expired - Fee Related
- 2000-12-27 AU AU30169/01A patent/AU782862B2/en not_active Ceased
- 2000-12-27 ES ES00990824T patent/ES2231304T3/es not_active Expired - Lifetime
- 2000-12-27 HU HU0203859A patent/HUP0203859A3/hu unknown
- 2000-12-27 NZ NZ520468A patent/NZ520468A/en unknown
- 2000-12-27 AT AT00990824T patent/ATE280752T1/de active
- 2000-12-27 RU RU2002120897/04A patent/RU2002120897A/ru unknown
- 2000-12-27 EP EP20000990824 patent/EP1246791B1/de not_active Expired - Lifetime
- 2000-12-27 CA CA002396310A patent/CA2396310A1/en not_active Abandoned
- 2000-12-27 WO PCT/EP2000/013282 patent/WO2001049651A2/de not_active Ceased
- 2000-12-27 PT PT00990824T patent/PT1246791E/pt unknown
- 2000-12-27 IL IL15055800A patent/IL150558A0/xx active IP Right Grant
- 2000-12-27 CN CNB008192669A patent/CN100467441C/zh not_active Expired - Fee Related
- 2000-12-27 SK SK980-2002A patent/SK286799B6/sk not_active IP Right Cessation
- 2000-12-27 DK DK00990824T patent/DK1246791T3/da active
- 2000-12-27 MX MXPA02006697A patent/MXPA02006697A/es active IP Right Grant
- 2000-12-27 SI SI200030587T patent/SI1246791T1/xx unknown
- 2000-12-27 DE DE50008447T patent/DE50008447D1/de not_active Expired - Lifetime
- 2000-12-27 JP JP2001550191A patent/JP2003519209A/ja active Pending
-
2001
- 2001-01-02 AR ARP010100008A patent/AR030683A1/es unknown
- 2001-01-04 PE PE2001000012A patent/PE20011043A1/es not_active Application Discontinuation
- 2001-01-04 CO CO01000529A patent/CO5261627A1/es not_active Application Discontinuation
-
2002
- 2002-06-20 NO NO20022983A patent/NO20022983L/no not_active Application Discontinuation
- 2002-07-03 IL IL150558A patent/IL150558A/en not_active IP Right Cessation
- 2002-07-05 US US10/189,184 patent/US6890959B2/en not_active Expired - Fee Related
- 2002-08-01 ZA ZA200206150A patent/ZA200206150B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69317992T2 (de) | Aminoketonderivate | |
| JPS6354321A (ja) | 血糖降下剤 | |
| ATE26112T1 (de) | Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung. | |
| RU2002120897A (ru) | Производные аминометилфенилциклогексанона | |
| GB1447611A (en) | Isoquinoline derivatieves and processes for their preparation | |
| RU95115237A (ru) | Новые производные пиридоновых кислот | |
| KR960031442A (ko) | 페닐시클로헥실카르복스아미드의 용도 | |
| KR910000647A (ko) | 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도 | |
| RU98122335A (ru) | Замещенные гетероциклические бензоциклоалкены и их применение в качестве субстанций с анальгезирующим действием | |
| JP2003519209A5 (enExample) | ||
| NZ205617A (en) | Pilocarpine precursors and pharmaceutical compositions | |
| ATE8045T1 (de) | Azolylalkyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
| KR900009677A (ko) | 신규 화합물들 | |
| CA2494176A1 (en) | Intermediates in producing phenoxyacetic acid derivatives and method of using the same | |
| KR880007506A (ko) | 카바모일옥시라브단, 중간체 및 그의 제조방법 및 용도 | |
| KR910000652A (ko) | (1,2,3,4-테트라하이드로-9-아크리딘이미노) 사이클로헥산 카복실산 및 관련 화합물, 이들의 제조방법 및 약제로서의 용도 | |
| US4119643A (en) | 4-Amino-6-nitro derivatives of 2H-3,4-dihydrobenzo[b]pyrans | |
| EP0351382A3 (en) | Process for the synthesis of optically active aminoacids | |
| GB2030984A (en) | alpha -aryl- alpha , alpha -bis[ omega -distributed amino)alkyl]-acetamides and related compounds | |
| JPH01221365A (ja) | 化合物の新規な製造方法 | |
| ATE304535T1 (de) | Verfahren zu herstellung von 3(2h)pyridazinon-4- substituierte amino-5-chloro derivate | |
| KR950032160A (ko) | 1-[2-1h-인덴-3-일)에틸]-4-(나프트-1- 일) 피페라진 유도체, 그의 제법 및 치료학적 이용 | |
| RU2000118317A (ru) | Производные пурина, обладающие ингибирующей активностью в отношении pde iv, и способы их синтеза | |
| DE69619402D1 (de) | Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten | |
| CA2561601A1 (en) | Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease |